Interactive Decision Support Tool

Share

Program Content

Activities

  • CLL Treatment Tool
    Expert Guidance for the Treatment of CLL
    Tool
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 22, 2022

    Expires: September 21, 2023

Faculty

cover img faculity

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Jennifer R. Brown, MD, PhD

Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
CLL Center Director and Institute Physician
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Jeffrey P. Sharman, MD

Medical Director of Hematology Research
Sarah Cannon at Willamette Valley Cancer Institute
Eugene, Oregon

Provided by

ProCE Banner

Supporters

AbbVie Inc.

AstraZeneca

Eli Lilly

Janssen Biotech

Pharmacyclics an AbbVie Company

TG Therapeutics

Partners

CLL Society

ProCE Banner